Search: onr:"swepub:oai:DiVA.org:umu-158081" >
Using germline vari...
-
Eckel-Passow, Jeanette E.
(author)
Using germline variants to estimate glioma and subtype risks
- Article/chapterEnglish2019
Publisher, publication year, extent ...
-
2019-01-08
-
Oxford University Press,2019
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:umu-158081
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158081URI
-
https://doi.org/10.1093/neuonc/noz009DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Background: Twenty-five single nucleotide polymorphisms (SNPs) are associated with adult diffuse glioma risk. We hypothesized that the inclusion of these 25 SNPs with age at diagnosis and sex could estimate risk of glioma as well as identify glioma subtypes.Methods: Case-control design and multinomial logistic regression were used to develop models to estimate the risk of glioma development while accounting for histologic and molecular subtypes. Case-case design and logistic regression were used to develop models to predict isocitrate dehydrogenase (IDH) mutation status. A total of 1273 glioma cases and 443 controls from Mayo Clinic were used in the discovery set, and 852 glioma cases and 231 controls from UCSF were used in the validation set. All samples were genotyped using a custom Illumina OncoArray.Results: Patients in the highest 5% of the risk score had more than a 14-fold increase in relative risk of developing an IDH mutant glioma. Large differences in lifetime absolute risk were observed at the extremes of the risk score percentile. For both IDH mutant 1p/19q non-codeleted glioma and IDH mutant 1p/19q codeleted glioma, the lifetime risk increased from almost null to 2.3% and almost null to 1.7%, respectively. The SNP-based model that predicted IDH mutation status had a validation concordance index of 0.85.Conclusions: These results suggest that germline genotyping can provide new tools for the initial management of newly discovered brain lesions. Given the low lifetime risk of glioma, risk scores will not be useful for population screening; however, they may be useful in certain clinically defined high-risk groups.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Decker, Paul A.
(author)
-
Kosel, Matt L.
(author)
-
Kollmeyer, Thomas M.
(author)
-
Molinaro, Annette M.
(author)
-
Rice, Terri
(author)
-
Caron, Alissa A.
(author)
-
Drucker, Kristen L.
(author)
-
Praska, Corinne E.
(author)
-
Pekmezci, Melike
(author)
-
Hansen, Helen M.
(author)
-
McCoy, Lucie S.
(author)
-
Bracci, Paige M.
(author)
-
Erickson, Bradley J.
(author)
-
Lucchinetti, Claudia F.
(author)
-
Wiemels, Joseph L.
(author)
-
Wiencke, John K.
(author)
-
Bondy, Melissa L.
(author)
-
Melin, Beatrice S.Umeå universitet,Onkologi(Swepub:umu)bema0010
(author)
-
Burns, Terry C.
(author)
-
Giannini, Caterina
(author)
-
Lachance, Daniel H.
(author)
-
Wrensch, Margaret R.
(author)
-
Jenkins, Robert B.
(author)
-
Umeå universitetOnkologi
(creator_code:org_t)
Related titles
-
In:Neuro-Oncology: Oxford University Press21:4, s. 451-4611522-85171523-5866
Internet link
Find in a library
To the university's database
- By the author/editor
-
Eckel-Passow, Je ...
-
Decker, Paul A.
-
Kosel, Matt L.
-
Kollmeyer, Thoma ...
-
Molinaro, Annett ...
-
Rice, Terri
-
show more...
-
Caron, Alissa A.
-
Drucker, Kristen ...
-
Praska, Corinne ...
-
Pekmezci, Melike
-
Hansen, Helen M.
-
McCoy, Lucie S.
-
Bracci, Paige M.
-
Erickson, Bradle ...
-
Lucchinetti, Cla ...
-
Wiemels, Joseph ...
-
Wiencke, John K.
-
Bondy, Melissa L ...
-
Melin, Beatrice ...
-
Burns, Terry C.
-
Giannini, Cateri ...
-
Lachance, Daniel ...
-
Wrensch, Margare ...
-
Jenkins, Robert ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Neuro-Oncology
- By the university
-
Umeå University